Penny Parker's Mile High Life: 'These cats may tickle your fancy'

Quoting from Penny Parker's new column, Mile High Life, in Denver's suburban newspaper consortium, Our Colorado News:

"Cat lovers can grab a kitty by the tail during Tails of the Painted Cats 2012, an auction and purr-fect dinner and gala July 28 at Lakewood Country Club to benefit the Cat Care Society...

...The event emcee is Ed Greene, CBS4 weather whiz. Auctioneers are Warren and Terri Smith of Two for the Show Auctions. Individual tickets for the gala are $75. New this year is a $100 patron ticket to a private VIP meet-and-greet prior to the dinner, where Greene will sign the 2013 "weather cat" painted cat.

The silent auction at the gala will include a Tower of Wine with 36 bottles (including pricey French labels and Marilyn Merlots) that attendees can bid on in addition to the Painted Cats...

...Tickets for the July 28 gala dinner and auction are available at: https://events.r20.constantcontact.com"

Link to Penny's column and pictures of several of the Painted Cats

Link to the Photo Gallery

North Denver Tribune: 'Tennyson Street Hosts Cat Care Society’s ‘Tails of the Painted Cats'’

Check out the 2012 Tails of the Painted Cats in the North Denver Tribune...

Online at http://www.northdenvertribune.com/2012/07/tennyson-street-hosts-cat-care-societys-tails-of-the-painted-cats/

Or via the July 19th print edition: http://www.northdenvertribune.com/print-version/

You'll find the hard copy Tribs at merchants and galleries throughout the Tennyson Street Cultural District where the cats have been on display this month and through noon tomorrow, Wednesday, July 25.

Thanks to Elisa Cohen, editor, and her team for showing off the 2012 Tails of the Painted Cats lineup at the TSCD!

DBJ & Denver Post: 'Denver Metro Chamber names Riebel its new chief operating officer'

Quoting from the July 20th posting by Kevin C. Keller:

"The Denver Metro Chamber of Commerce announced Friday that Holli Riebel will be its new chief operating officer.

Riebel will join the chamber Aug. 19. She was formerly chief executive officer of the Colorado Bioscience Association. She formerly served on the chamber's economic development entity, and was with Jefferson Economic Council for seven years...

...The Colorado Bioscience Association has named April Giles, executive vice president to oversee its day-to-day operations as a formal search for a replacement begins.

Link to the Denver Post

Quoting from the July 20th Denver Business Journal by Greg Avery:

"Holli Riebel has been named chief operating officer of the Denver Metro Chamber of Commerce, effective Aug. 19.

Riebel is currently president and CEO of the Colorado BioScience Association, the trade group representing the state’s biotechnology and medical device industries and related academic research institutions...

...She took leadership of CBSA two years ago. She will remain at the CBSA until Aug. 17.

Steve Orndorff, chairman of the 350-member association’s board and CEO of Ariel Pharmaceuticals said in a note to members Friday that Riebel has been a strong asset for the CBSA.

'She has accomplished a number of goals and led the organization to many successes,' he wrote. 'I can say unequivocally that CBSA is stronger than ever due to Holli’s effective leadership.'

April Giles, CBSA executive vice president, will oversee the association’s day-to-day operations following Riebel’s departure. The association’s board plans to meet soon the start organizing the national search for a permanent president and CEO."

Link to the Denver Business Journal

Aurora Sentinel: 'Colorado makes its mark in bioscience as the industry roars to life nationwide'

Quoting from the July 17th Aurora Sentinel article by Brandon Johansson:

"The Colorado BioScience Association also pointed to what it sees as continued growth in 2012 and beyond, including the addition of a new wing at the Fitzsimons redevelopment Authority’s headquarters in the Fitzsimons Life Science District in Aurora as well as several other expansions by Colorado companies this year.

'These elements together with over 600 bioscience companies, led by the best in the industry, generate a critical mass that really puts Colorado on the map,' President and CEO of the Colorado BioScience Association Holli Riebel said. 'We're proud to announce our industry achievements and create a dialog with investors and partners that Colorado is a great place for bioscience.'"

Link to the Aurora Sentinel

Blacktie Colorado/Penny Parker On The Town: 'Cat scratch fever heats up charity gala and auction'

Quoting from Penny Parker's recent Blacktie Colorado column:

"Cat lovers can grab a kitty by the tail during Tails of the Painted Cats 2012, an auction and purr-fect dinner and gala July 28 at Lakewood Country Club to benefit the Cat Care Society.

The pretty kitties, created by juried artists, are on display at various galleries and businesses in the Tennyson Street Cultural District during July.

Event emcee is Ed Greene, CBS4 weather whiz. Auctioneers are Warren and Terri Smith of Two for the Show Auctions. Individual tickets for the gala are $75. New this year is a $100 patron ticket to a private VIP meet and greet prior to the dinner where Greene will sign the 2013 “weather cat” painted cat."

Link to Blacktie Colorado

Remember - we're just days away from the Tails of the Painted Cats Gala Dinner & Auction at the Lakewood Country Club.

Bid on Painted Cats in Advance: http://BidOnACat.blogspot.com

Order tickets for the Final Auction Gala online: https://events.r20.constantcontact.com/register/eventReg?oeidk=a07e5rymoroc74ec81a&oseq=

CBSA Announces BioWest 2012 Rundown + Unveils Venture Showcase Finalists

The Colorado BioScience Association (CBSA) announces the 9th BioWest Conference, September 11, 2012, at the Marriott City Center, Denver. The announcement is made by CBSA President & CEO Holli Riebel, who says, “BioWest is the Rocky Mountain region's premier medical device and biotechnology conference and the venue of our much anticipated Venture Showcase competition. We've now selected the six finalists for this year's Venture Showcase and are thrilled by the amazing new technologies that will be presented at BioWest in September."

The six finalists in the 2012 Venture Showcase competition include:

Flashback Technologies Inc. - Longmont, CO - is developing and commercializing product applications of its proprietary software algorithm platform called CipherSensorTM Technology. The first product application is in the medical trauma setting enabling the immediate, noninvasive detection of the risk for cardiovascular collapse and monitoring of the effectiveness of fluid resuscitation therapy. http://www.flashbacktechnologies.com  

KromaTiD - Fort Collins, CO - makes products for analyzing defects and damage to human chromosomes. The company is launching the first commercial platform for the discovery and detection of a recalcitrant class of DNA mutations known as Chromosomal Inversions. http://www.kromatid.com  

Siva Therapeutics Inc. - Boulder, CO - is developing a method for cancer therapy which promises to be safer, with fewer side effects, and at least as effective as current therapies. The company’s approach is precision photothermal treatment of solid tumors using targeted gold nanorods - SivaRods™. http://www.sivatherapeutics.com  

Sophono Inc. - Boulder, CO - has developed the world’s first non-percutaneous, implantable, bone-anchored hearing device. The company’s Alpha 1 System eliminates the problematic abutment of other devices by using magnets to securely affix the external sound processor to a titanium implant. http://www.sophono.com  

SuviCa Inc. - Boulder, CO - is a biotechnology company focused on the discovery and development of small molecule drugs for oncology. The company’s family of compounds target a process crucial for cancer growth but under-utilized as a drug target. http://www.suvica.com  

VetDC Inc. - Fort Collins, CO - is an emergent veterinary biotechnology company that licenses innovative human biomedical technologies to address serious unmet medical needs in companion animals. The company’s lead candidate is a novel anti-cancer drug. http://www.vet-dc.com  

The Venture Showcase finalists pitch their technologies and business plans in front of a live audience at BioWest to a panel of bioscience experts and venture capitalists. The winner, announced at the end of the conference day, will receive a $7,500 cash prize.

Link to Register for BioWest 2012

Link to the Business Wire Posting

Link to the PitchEngine Social Media Release

DBJ: 'Fitzsimons changes focus to better nurture startups'

Quoting from the article by Greg Avery on Steve VanNurden, recently appointed Pres/CEO of the Fitzsimons Redevelopment Authority:

"VanNurden’s hiring completes a shift making the FRA less of a real estate organization and one more focused on helping to attract and find resources for medical and technology businesses that want to be in the park.

'Rather than make this a real estate play, we’re going to make this a biosciences community,' he said. 'We have all the ingredients to be able to do that; we just need to put them in the right places.'. .

. . . . Near VanNurden’s office door, construction workers are finishing the interior of an $8 million expansion of the building that houses the FRA headquarters and 3½ floors of labs and offices for 38 bioscience startups, most of which come from the university labs across the street.

The new wing was considered speculative development when it was announced two years ago, but demand for it proved strong.

The expansion opens July 25, and it will be 90 percent occupied. Four companies — Isogenis, Inc., LightLabs, Mitomics and Touch of Life Technologies — are moving in. They outgrew their space in the bioscience incubator building, said Vicki Jenings, the FRA’s director of business relations.

VanNurden hopes the growth of companies incubated on the campus will drive demand for more buildings, and that some large companies result from the homegrown tenants.

He plans to look beyond the FRA’s immediate surroundings for tenant companies. He envisions the park one day attracting computer technology companies and clinical-trials management companies, not just strictly drug and medical-device research companies. . .

. . . On July 3, VanNurden realized a longtime industry contact had a layover at DIA. VanNurden — who declined to identify that person’s company, saying only that it’s well-known — picked up the person and his colleagues, and gave them an impromptu tour of Fitzsimons and information about the work being done on the campus before returning them to DIA.

'They didn’t know what this was, and they were very interested to discover what’s going on here,' he said."

Link to the Denver Business Journal